Streetbeat News

Products Services

BCAN

BYND Cannasoft Enterprises Inc. (NASDAQ:BCAN) announced a new plan of work focusing on its proprietary CRM platform to meet the increased demand for medical cannabis in Israel. This follows recent regulatory reforms allowing cannabis as a first-line treatment, leading to a surge in licensed medical cannabis patients. The company's Benefit CRM helps optimize functions like sales management and asset management. The software development phase will focus on AI elements to increase data collection and analysis. In February 2023, BYND Cannasoft received a full license to trade in medical cannabis products.

Portfolio Pulse from Benzinga Newsdesk

November 07, 2023 | 1:34 pm

QLGN

Qualigen Therapeutics, Inc. (NASDAQ:QLGN) has announced the first patient dosing in the Phase 1a clinical trial of QN-302, a potential treatment for advanced or metastatic solid tumors. The trial is being conducted at START Midwest in Grand Rapids, Michigan. QN-302, a G-Quadruplex (G4)-selective transcription inhibitor, was licensed by Qualigen in January 2021 and received Orphan Drug Designation for the treatment of pancreatic cancer. The company expects to provide an update on the trial's safety and preliminary efficacy in the first half of 2024.

Portfolio Pulse from Benzinga Newsdesk

November 07, 2023 | 1:33 pm

BTDR

Bitdeer Technologies Group (NASDAQ:BTDR) announced its unaudited mining and operations updates for October 2023, revealing a 173.4% increase in Bitcoin mined compared to October 2022. The company's Gedu Datacenter in Bhutan contributed to this strong performance, providing a 3.3EH/s hash rate and mining 211 Bitcoins. Bitdeer is also advancing the construction of a 175MW immersion cooling datacenter at its Tydal, Norway mining facility, expected to be completed in 2025.

Portfolio Pulse from Benzinga Newsdesk

November 07, 2023 | 1:32 pm

BEAT

HeartBeam has been granted a US patent for a 12-lead extended wear patch for detecting heart attacks and complex cardiac arrhythmias. The company's stock, BEAT, may be impacted by this news.

Portfolio Pulse from Benzinga Newsdesk

November 07, 2023 | 1:32 pm

HON

WFRD

Weatherford International plc (NASDAQ:WFRD) has signed a memorandum of understanding with Honeywell (NYSE:HON) to deliver a combined CygNet™ SCADA and Honeywell Emissions Management suite for advanced emissions management. The integrated system will facilitate immediate access to essential data, enhance operational efficiency, and help customers achieve decarbonization targets.

Portfolio Pulse from Benzinga Newsdesk

November 07, 2023 | 1:31 pm

SLRX

Salarius Pharmaceuticals has completed an FDA Type B meeting for its Seclidemstat Ewing Sarcoma development program. The meeting is a significant step in the drug's development process.

Portfolio Pulse from Benzinga Newsdesk

November 07, 2023 | 1:30 pm

PXMD

PaxMedica has announced the publication of its Autism Spectrum Disorder Phase 2 study results in a peer-reviewed journal. The results of the study could have significant implications for the company's future developments and stock performance.

Portfolio Pulse from Benzinga Newsdesk

November 07, 2023 | 1:29 pm

SNTI

VTYX

Several stocks are experiencing significant pre-market movements. Senti Biosciences, Tharimmune, TransMedics Group, GSE Systems, Unisys Corporation, Alteryx, Augmedix, Color Star Technology, CF Acquisition Corp. IV, and Tripadvisor reported gains due to various reasons such as strategic collaborations, licensing agreements, better-than-expected Q3 results, and strong FY23 revenue guidance. On the other hand, Ventyx Biosciences, Alto Ingredients, MSP Recovery, Coherus BioSciences, Ameresco, Aura Biosciences, Clover Health Investments, Trevena, Tenon Medical, and NanoString Technologies reported losses due to reasons such as disappointing trial results, mixed Q3 results, and weak quarterly sales.

Portfolio Pulse from Lisa Levin

November 07, 2023 | 1:28 pm

NFLX

Netflix has announced that it will increase its subscription prices ahead of the holiday season. The price hikes are expected to affect all of its U.S. customers.

Portfolio Pulse from Benzinga Newsdesk

November 07, 2023 | 1:27 pm

AAPL

QCOM

SSNLF

Leaked benchmarks suggest that Samsung's upcoming Galaxy S24 could be a strong competitor to Apple's iPhone 15 Pro. The Galaxy S24 Ultra, powered by Qualcomm's Snapdragon 8 Gen 3 chipset, has recorded impressive scores on Geekbench listings, although slightly lower than the iPhone 15 Pro Max. Samsung aims to ship 35 million units of the Galaxy S24 series in 2024, a 10% increase from the Galaxy S23’s 31 million units. The company is also incorporating AI technology and high-quality materials in its aggressive strategy to capture a larger market share.

Portfolio Pulse from Rounak Jain

November 07, 2023 | 1:26 pm